86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us


Chengdu Baiyu Pharmaceutical Co.,Ltd

Products >> Ginkgolide Injection

Ginkgolide Injection

Build Your Online Product Catalogs?



Description
Product Name: Ginkgolide Injection
Supply Ability:
Related proudcts injection, ginkgolide,
Specifications 2ml
Price Term:
Port of loading:
Minimum Order
Unit Price:

Active ingredients: bilobalide, ginkgolide A, ginkgolide B and ginkgolide C.
Description: a colorless or pale-yellow clear liquid.
Dosage Form: liquid injection.
Indications: For mild to moderate cerebral infarction, symptoms are hemiplegia, deviated tongue, paralalia and paraesthesia, etc.
Strength: 2ml/ampoule, containing 10mg ginkgolide.
Storage: Keep airtight in a dark and cool place.
Packaging: ampoule, 5 ampoules/box (Can be customized based on customer's order.)
Shelf Life: 24months.
Dosage and Administration:
Administrated by intravenous infusion. The recommended dose is 5 bottles (10ml). Before use, add the powder into 250ml of 0.9% sodium chloride injection or 250ml of 5% glucose injection for dilution and administrated as a slow intravenous infusion. Give the dosage once a day; during the infusion, strictly control the rate ranging from 40 to 60 drops per minute. The course of treatment is 14 days.
Contradictions:
1. Patients with a history of hypersensitivity or adverse reaction to the product or any other finished ginkgo products.
2. Patients with a history of hypersensitivity to ethanol, glycerin, ethanol (alcohol) and glycerol.
3. Contradicted in pregnant and lactating women.
Pharmacology and toxicology:
The results of non-clinical pharmacodynamic study showed that the product can reduce the stroke score, the mortality rate and the cerebral infarction area in the rat focal cerebral ischemia model using the suture method; can promote the recovery of amplitude of EEG potential, can reduce cerebral water content in the gerbil cerebral ischemia-reperfusion model; can reduce brain wet weight, brain index, cerebral water content in the rat cerebral ischemia-reperfusion model using 4-vessel occlusion method, reduce the damage of hippoca***l CA1 (increase the density of neuron in the region).
Contact Information:
If you are interested in the above product, please feel free to contact us.
Tel: +86 28 83379750 Ext.8011
Email: sales@baiyu.cn
Address: No.343, HeZuo Road, West Hi-Tech Z

Contact Us
Company: Chengdu Baiyu Pharmaceutical Co.,Ltd
Contact: Ms. Lily He
Address: No.343, HeZuo Road, West Hi-Tech Zone
Postcode: 611730
Tel: +86 028-83379750
Fax: +86-28-61683990-8004
E-mail:         


Copyright© Chengdu Baiyu Pharmaceutical Co.,Ltd All Rights Reserved.
Tel : +86 028-83379750 Fax : +86-28-61683990-8004
Powered by 86exporter.com